Artificial Intelligence for the Good of Healthcare

Artificial Intelligence for the Good of Healthcare

Artificial intelligence (AI) has the potential to revolutionize drug development by leveraging real-world data (RWD) from electronic health records, claims data, patient registries, and wearable devices. AI can analyze and integrate large amounts of disparate data quickly and accurately, identifying patterns and making reliable predictions. This can enhance decision-making, improve patient outcomes, and increase clinical trial success rates. Although AI promises substantial benefits, it is not free of challenges. Data fragmentation, accuracy, and ethical considerations must be addressed.

Learn more about Opportunities for Responsible AI in Clinical Research & Drug Development by downloading a copy of our ebook where we explore:

• The current state of drug development.

• Clinical trial data and RWD — their roles and impacts on the life sciences industry.

• AI’s potential in harnessing RWD to revolutionize research and development, including key use cases for the promising technology.

• The responsible use of AI in advancing scientific discoveries and improving healthcare.